Synageva BioPharma Announces Closing of Public Offering and Exercise of …
LEXINGTON, Mass., Jul 13, 2012 (BUSINESS WIRE) — Synageva BioPharma Corp. ("Synageva") (NASDAQ:GEVA) , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the closing of a $115 …
See all stories on this topic »